Effective October 2025, ICD-10-CM code E78.01 (Familial hypercholesterolemia) has been deleted and replaced with new, more specific codes. New Codes: What You Need to Know: Why This Matters: Action Steps for Providers: This update is part of the annual ICD-10-CM guidelines and aims to improve the accuracy of patient diagnosis, billing, and research data. Please
We’re excited to share two new resources designed just for you and your patients: “What to Expect When Starting Liposorber Treatment” – for adults and pediatrics. These short, patient-friendly videos walk through the therapy experience, step-by-step. Whether you’re onboarding a new patient or reinforcing long-term adherence, this video helps patients feel informed, confident, and supported. It provides guidance for
Peripheral Arterial Disease Associated with Elevated Lipoprotein(a): A Review of the Evidence and Treatment ApproachesCurrent Opinion in Lipidology, May 21, 2025Bhatia, Harpreet S.a; Dalal, Sonarb; Ross, Elsiec Why This Matters to Your Practice: This comprehensive review consolidates clinical evidence linking elevated Lp(a) to the onset, severity, and outcomes of PAD. Highlights include: Review Topics Include: Among
At UCHealth University of Colorado Hospital, our LIPOSORBER (Lipid Apheresis) treatment is available, making it the only facility in Colorado and the surrounding region offering this potentially life-saving procedure. According to a recent American Heart Association study, lipid apheresis is a “valuable but underused” therapy for patients with severe cholesterol disorders such as familial hypercholesterolemia
New York, January 29, 2025 We are pleased to announce an important update regarding Kaneka’s LIPOSORBER® LA-15 System Indications for clinically diagnosed Familial Hypercholesterolemic patients. As part of our ongoing commitment to advance patient care and support healthcare providers in properly managing these patients, we have received approval for improved indications that enhance the utility
